Vaisala acquires Veriteq
Vaisala has strengthened its position in the life science market through the strategic acquisition of Veriteq Instruments Inc, a continuous monitoring system and data logger company based in Canada.
Veriteq is a provider of productised continuous monitoring systems and data logger solutions for the life science industry comprising pharmaceutical, biotechnological and medical device companies.
Life science is a focus area for Vaisala's Controlled Environments business, and the acquisition of Veriteq, with its life science emphasis, aligns with Vaisala's strategy.
"Vaisala is currently known as an instrument provider in the global pharmaceutical market. We want to strengthen our position by expanding our offering both to pharmaceutical and other life science customers. The Veriteq acquisition is a major step towards this goal, bringing additional know-how, a customer base, products and services to Vaisala," says Pirjo Kortteisto, Director of Cleanrooms and Chambers market segment.
Epilepsy pioneer elected President of Aust Academy of Science
Laureate Professor Sam Berkovic — one of the world's most respected neurologists...
CSIRO announces 300+ job cuts as part of restructure
CSIRO will need to reduce roles in its Research Units by 300–350 full-time equivalent staff...
Synchron raises $305m to advance brain–computer interfaces
Synchron's Stentrode BCI platform is billed as the world's first endovascular...
